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Abstract
Modern 3D bioprinters have been shown to allow for
precise control of structural geometry to build patientspecific scaffolds for tissue regeneration—primarily nonload-bearing tissue. However, 3D bioprinting is limited
by cell viability, polymer cross-linking characteristics, and
poor tensile properties. In comparison, electrospinning
has been used to form fibrous structures with accelerated
cellular maturation properties, improved growth and
migration of cells, and increased tensile properties.
Conversely, the mostly uncontrolled deposition of
electrospun fibers can limit pore size and cell infiltration.
In our Orthopaedic Biomechanics & Biomaterials
Laboratory, a custom 3D Bioprinter + Electrospinner
hybrid system (E-Spin Printer) was designed to merge
the positive aspects of both technologies to allow for
hierarchical, functionally-graded scaffolds with high
load-bearing characteristics. This hybrid system was made
from open-source components and is customizable to
meet the accuracy, resolution, and repeatability of highend bioprinters and electrospinners, at a cost of less than
$10,000. We introduce this technology and provide a broad
description of one application for its use.

Introduction
3D bioprinting can be defined as the printing of biopolymer
and high-concentration cell solutions. Typically, 10 to 1000
μm resolution is required to form tissue-like structures,
with higher-viscosity materials often providing structural
support for the printed structure and lower-viscosity
materials providing a suitable environment for maintaining

cell viability and function. Laboratories across the world
have designed and created 3D bioprinters to fabricate
replacement human-scale tissues and organs, often with
structural integrity and biological function similar to
native tissues. These printed structures have been shown
to be stable and amenable to revascularization, making
them ideal for application in replacement of injured tissue.
At this time, few bioprinter systems have been targeted
toward fabricating tissue with high tensile and compressive
strength requirements.
The main steps in the 3D bioprinting process are
imaging and digital design, selection of materials and cells,
and printing of the scaffolds.1-6 Imaging such as computed
tomography (CT) and magnetic resonance imaging (MRI)
are essential to replicate the complex, heterogeneous
architecture of functional tissues. Further segmentation,
surface rendering, and stereolithographic editing can
provide a full volumetric description of the specific tissue
examined. Computer-aided design and computer-aided
manufacturing (CAD-CAM) tools and mathematical
modeling techniques can then be used to collect and
digitize the complex tomographic and architectural
information. This is followed by deposition and patterning
of materials in successive layers as directed by the CADCAM software, wherein each deposited layer serves as a
foundation for the following layers until the 3D structure
is patterned and completed (Figure 1A). Inkjet, microextrusion, and laser-assisted printing can all be used for
deposition and patterning tissue materials.1-6
The electrospinning fabrication technique uses high
voltage (5 to 30 kV) to create an electric field between a
droplet of polymer solution (typically at the tip of a syringe
needle) and a metallic collector plate (Figure 1B). The main
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forces acting on the polymer droplet are the electrostatic
field and the electrostatic repulsion of charges. These
forces are opposed by the surface tension of the droplet,
and the viscoelastic forces of polymer. When electrostatic
repulsion charges exceed the surface tension, stretching
(ie, elongating at very high strain rates) of the polymer
droplet occurs, and a continuous fiber is ejected toward the
collector plate. Polymer solution viscosity, surface tension,
electrical conductivity, and dielectric constant are key
parameters for the electrospinning process controllable by
solution selection and optimization. Applied voltage, flow
rate of solution, collector material properties, diameter of
the needle, and distance between applicator and collector
are other key parameters of the electrospinning process
controllable by hardware setup, selection, and design.
Temperature, humidity, and pressure should also be
considered.7,8

A

that contain properties amenable to extrusion and
cellular viability do not adhere to rigid structures without
considerable material modifications. The geometric
control allowed by 3D printing will enable patient-specific
reproductions of the hard and regeneration of soft tissue.
The cost of isolated electrospinners ranges from $25,000
to $50,000 with electrospray capabilities. Entry-level
3D bioprinters commercially range from $75,000 to
$500,000 with multiple nozzles and additional features for
polymerization of materials.
We introduce the development of a low-cost, modular
3D Bioprinter + Electrospinner hybrid system (E-Spin
Printer) for targeted fabrication of scaffolds of the bone,
ligament, and bone-ligament interface. This system aims to
merge the positive aspects of each technology. We present
a summary of the developed technology and describe an
application for its use. All fabrication and experimental
validation was completed our Orthopaedic Biomechanics
& Biomaterials Laboratory.

Design

B

The design of our technology is presented henceforth. It is
important to note that while we describe specific materials
used in development of the first prototype, the design
is universal such that similar materials from different
manufacturers may serve the same purpose.
Stepper Motor Controller

Figure 1. (A) Representative example of 3D bioprinting using multiple
bioinks deposited from their respective syringe deposition systems.
(B) Representative schematic describing the primary characteristics of
an electrospinner.

Traditionally, electrospinning processes have control
over microstructural porosity, density, and tensile strength
while lacking macroscale geometric control. Porosity and
density control has been shown to enable cellular migration,
elongation, and proliferation needed for differentiation of
mesenchymal stem cells to ligament fibroblasts. The tensile
strength characteristics will enable properties closer to that
of native ligament than other biomanufacturing techniques.
Electrospinner characteristics contrast to those of the
3D-bioprinting process that allows for geometric control
but lacks a process to vary microstructural properties.
Shortcomings of 3D bioprinting are especially limiting
when tissues must be attached to bone; the materials
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The printer is controlled by a Smoothieboard 5x, a low
cost (< $200), open source stepper motor controller with
flexible software configuration (Uberclock, Gold Hill, OR).
The controller runs five stepper motors simultaneously,
with up to 2.5 amps of current when powered with a
24-volt power supply. Our printer uses five motors in
its current design: three for X, Y, Z motion and two to
drive custom syringe pumps (one for printer, one for
electrospinner). The other inputs of the Smoothieboard
could also run several cooling fans and multiple heated
beds, and the inputs are compatible with most opensource software. The controller was chosen for its flexible
hardware and software configurations and extensive online
documentation. As additional print heads or other items
are added to the system, it may be necessary to add a larger
controller or additional controllers to handle the added
components.
Linear Stages
For X, Y, and Z axis movement, we purchased several
Newmark eTrack linear stages for their specified resolution,
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accuracy and repeatability (Newmark Systems Inc,
Rancho Santa Margarita, CA). Each stage was fitted with a
NEMA 17 stepper motor rated at 1.2 amps. The leadscrew
configuration of the linear stages allows for more precise
movement over belt-driven stages at the cost of speed. The
X stage is 300-mm long, whereas the Y and Z stages are
200 mm and 150 mm, respectively. The X stage enables
positioning of the build plate under the 3D bioprinter or
electrospinner deposition heads, respectively. The Y stage
is mounted orthogonally to the X stage for front-to-back
plate positioning. The Z axis is vertically mounted to the
frame of the printer, allowing for height control of the print
nozzle. Newmark rails range from $782 (50 mm) to $962
(300 mm). The selected rails have a 0.24-mm resolution, an
accuracy of 0.0006 mm/mm, and a max speed of 150 mm/s.
Figure 2 shows the X, Y, and Z rails mounted in the frame
of the E-Spin Printer.

Figure 3. Close-up view of an early embodiment of our hybrid system
showing the build plate (asterisk), bioprinter syringe pump (left
arrow), and electrospinner syringe pump (right arrow).

Syringe Pumps

Figure 2. Early embodiment of our E-Spin Printer hybrid system. X, Y,
and Z linear stages are noted with arrows showing axis of travel.

The extrusion system consists of two custom syringe
pumps that were constructed using 3D-printed nylon and
off-the-shelf hardware (Figure 3). The design borrows
and improves on the open-source OpenPump system and
is one of the most cost-effective ways to create a syringe
pump. To reduce torsion during syringe deposition, the
end-mounts were redesigned to attach directly to a custom
base plate that fixed to the Z axis of the printer frame. The
fixture that holds the syringe plunger was modified to
allow easy access to slide bearings and improve grip on the
plunger of the syringe during deposition. Each pump was
fitted with a NEMA 17 stepper motor controlled by the
Smoothieboard. The hardware consists of an M5 threaded
rod, M8 smooth rods, couplers and slide bearings.

Print Bed

Electrospinner

The custom print bed was designed as a surface for
printed material and an electrical conductor for the
electrospinner of the system. The print bed is a layered
system of acrylonitrile-butadiene-styrene (known as ABS)
plastic, rubber, nylon, aluminum, and glass supported
by three leveling screws (Figure 3). The aluminum layer
is machined to allow insertion of a 4- by 6-inch heated
polychlorinated-biphenyl (PCB) bed. To help reduce
unwanted conductivity from the electrified print bed
during electrospinning, a 1-inch air gap was designed
between the print bed and Y-linear stage. Additionally, the
print bed is attached to the linear stage using nylon screws
to further reduce unwanted electrical charge throughout
the system.

The electrospinner consists of a steel syringe tip, the
aluminum plate of the print bed, and a low-cost ($250)
5- to 30-kV variable high-voltage power supply purchased
from Information Unlimited (Amherst, NH). The power
supply was chosen for its low cost and safety features,
specifically, a current limiting feature to reduce risk of
shock or injury, which lowers amperage to safe levels (700
µA at 35 kV). In operation, the negative lead of the power
supply clamps directly to the aluminum plate of the build
plate, and the positive lead connects directly to the steel
needle of the mounted syringe. As voltage is increased, an
electric field is created between the syringe needle and
print bed. Solution exiting the syringe becomes charged
and quickly collects on the glass surface of the negatively-
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charged build plate (Figure 4).
Our system also includes a modification to allow
for aligned fiber spinning. For this, the negative lead is
replaced by two negative leads, each is connected to a
single extruded metal bar positioned on either side of the
desired print surface, near the target area. The negative
leads are triggered in an alternating fashion to direct
flow of the solution exiting the syringe, back and forth
depending on the activated lead.

A

B

C

D

E

Figure 5. Flowchart showing representative process for moving from
computed tomography and magnetic resonance imaging (MRI) to
implantation.

Slicing Software

Figure 4. Close-up view of electrospun fiber deposition on build-plate
(white). Note the white lead at the bottom that provides a negative
charge to the plate.

3D-Modeling Software
All initial 3D modeling was created using OpenSCAD, an
open-source CAD program. The program was free under
the General Public License and allowed for rapid modeling
and stereolithography file exporting. When moving toward
patient-specific modeling of hard and soft-tissue scaffolds,
we will use Mimics (Materialise, Leuven, Belgium) CT and
MRI to 3D-modeling software and MedCad (Dallas, TX)
for integrating the scaffolds with surrounding hard tissue.
A flowchart of the planned steps for fabrication are shown
in Figure 5. In short, a torn ligament would be identified
through CT or MRI (A). The data can be exported to a
medical imaging software to develop a 3D model of the
bone and insertion points (B). The software can be used
to simulate native tissue replacement. Solid files can be
exported and read by the E-Spin Printer and converted to
G-code for fabrication (C). The scaffold is built and cells
are seeded for growth (D). The scaffold can be immediately
implanted into a patient, or the tissue can be grown fully
before implantation (E).
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Our printer currently uses the open-source program Slic3r
to generate G-code for construction. Slic3r was chosen
because, with some code modification, it allows the user
to assign extruders (ie, syringe pumps) to each material
to be printed or spun. This feature was exploited to allow
our machine to alternate between our syringe pumps (each
holding different materials). By exploiting this feature,
we are also able to create a gradient between materials in
all directions (X, Y, Z). More on material deposition is
described in subsequent sections. Currently, popular opensource 3D slicing software is not optimized for bioprinting.
Future embodiments of our technology will require
advanced customization of the Slic3r software to allow for
use of three or more bioinks and electrospun filament.
Potential Fabrication Materials
3D bioprinter—synthetic and natural bioinks. Alginate
was chosen as a suitable hydrogel to validate our
3D-bioprinting technology. An alginate-based bioink was
printed, and hydroxyapatite (HAp) bioceramic particles
were added to enhance mechanical properties to ensure
a functionally graded bone-ligament interface transition.
Notably, alginate requires mixture with calcium ions for
polymerization. Thus, this material may not be suitable for
use in mammals owing to calcium ion leaching that would
surely occur. Thus polyethylene (glycol) diacrylate (known
as PEG-DA) with a photoinitiator has been selected as
a new printing material to control viscosity by addition
of exfoliated clay9 or HAp nanoparticles. Note that the
current design is not limited to any polymer type, but
some polymers may require implementation of additional
materials or hardware to aid in polymerization. e.g. A
photoinitiator and UV lighting system may be required for
polymerization. It is important to also note that cells can
be included in the composition of the bioink. The cellinfused bioink is transported via syringe pumps through
the system. When cells are included, further optimization
of the syringe pump control will be needed to maintain
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cellular viability. Additionally, we are working with a
collaborator for printing of cell-encapsulating proteins that
would aid in direct-cell printing.
Electrospinner—synthetic and natural polymers.
Polycaprolactone (PCL) was chosen as a primary test
material because it has been shown to be a suitable,
biocompatible polymer for electrospinning.10,11 However,
collagen will be used in future iterations because of its
function as a component of extracellular matrix (ECM) in
connective tissues.12 This makes it a more suitable choice
for electrospun connective-tissue scaffolds. Collagen
fiber alignment is essential for scaffold architecture and
mechanical properties. Moreover, the use of collagen fiber
diameter has been critical in the design of scaffolds because
it is deterministic of scaffold mechanical properties, cell
proliferation, matrix production, and differentiation
regulation.13

Application
As a first application of our technology, we aim to print a
patient-specific bone-ligament scaffold for regeneration of
the scapholunate ligament.
Problem
The scapholunate ligament has been identified as the
most commonly injured hand ligament by the American
Society for Surgery of the Hand.14 Ligament healing is not
common owing to a reduced number of cells and blood
vessels that exist in and around the soft tissue. Healing,
usually in partial tears of the ligament, is often a result of
scar-tissue formation. For full ligament ruptures, the most
common surgical treatment is ligament reconstruction,
usually with a tendon harvested from the upper extremity.
Unfortunately, autographs have been shown to cause
donor-site morbidity and do not match the mechanical
properties of the native tissue. Therefore, orthopaedicrelated research has focused on strategies to improve and
accelerate the healing process through tissue-engineered
scaffolds.15-18
Notable Considerations in Tissue Engineering
When designing and assessing a scaffold for use in tissue
engineering, the following six factors should be considered:
1) Biocompatibilty: scaffolds should be biocompatible for
cells to adhere, function, and migrate onto the surface and
through the scaffold. Scaffold implantation must evoke
a negligible immune reaction to prevent any excessive
inflammatory responses. 2) Biodegradability: scaffolds
are not intended to be a permanent implants and should

eventually be replaced by native tissue. The scaffold
degradation byproducts should not be cytotoxic. 3)
Mechanical properties: scaffolds should have mechanical
properties (ie, strength and stiffness) consistent with the
anatomical site into which it is to be implanted. Moreover,
scaffolds should be practically strong enough to allow
for manual manipulation during surgical procedures. 4)
Mechanical integrity: scaffolds should have sufficient
mechanical integrity to function from the time of
implantation to completion of the remodeling process
of native tissue. 5) Scaffold architecture: scaffolds should
accommodate cellular penetration and adequate diffusion
of nutrients and waste products to and from cells. 6)
Fabrication technology: scaffolds should be cost effective
and patient specific to be commercially and clinically
viable.1,18
Scaffold Fabrication Process
The introduced E-Spin Printer system allows for a
functionally-graded (laterally), alternating layer (vertically)
deposition method. The novelty of our technology, using
a single X-Y rail system underlying the 3D bioprinter and
electrospinner syringe pumps, respectively, allows for
this unique deposition method. The functionally-graded
characteristic will allow a gradual transition, horizontally,
from the bone phase to ligament phase then back to bone
phase using bioinks from multiple syringes—each with
a varying concentration of HAp nanoparticles and other
necessary material modifiers. The bulk scaffolds will vary
vertically made from alternating layers of PEGDA-based
bioink (or other) and PCL (collagen, or other) electrospun
fibers (Figure 6).
The bioinks will be tuned to serve as a viable ECM
environment to support cell migration, growth, and
proliferation. To aid in this, some bioinks will be fabricated
from decellularized human tissue such that the ECM
environment is maintained to support desired cellular
activity. The electrospun fibers will be tuned to support
high tensile loads such as those experienced by the native
ligament; these fibers provide most of the mechanical
stability and strength of the bulk scaffold. Multiscale
material and structural optimization will be required
to control microstructure, mechanical properties, and
biodegradation rates of the scaffold.
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Figure 6. Schematic representation of the (Left) hierarchical and (Right) functionally-graded composite scaffold targeted with this technology.

Conclusion
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